Cas Medical Systems Inc (NASDAQ:CASM) Shifting Institutional Investors Sentiment

June 20, 2017 - By Ellis Scott

 Cas Medical Systems Inc (NASDAQ:CASM) Shifting Institutional Investors Sentiment

Sentiment for Cas Medical Systems Inc (NASDAQ:CASM)

Cas Medical Systems Inc (NASDAQ:CASM) institutional sentiment increased to 1.6 in 2016 Q4. Its up 1.04, from 0.56 in 2016Q3. The ratio is better, as 8 institutional investors opened new and increased stock positions, while 5 decreased and sold their equity positions in Cas Medical Systems Inc. The institutional investors in our partner’s database reported: 8.61 million shares, down from 8.85 million shares in 2016Q3. Also, the number of institutional investors holding Cas Medical Systems Inc in their top 10 stock positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 3 Increased: 4 New Position: 4.

CAS Medical Systems, Inc. is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The company has market cap of $27.96 million. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It currently has negative earnings. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales.

The stock increased 0.99% or $0.01 on June 19, reaching $1.01. About shares traded. CAS Medical Systems Inc (NASDAQ:CASM) has declined 47.56% since June 20, 2016 and is downtrending. It has underperformed by 64.26% the S&P500.

Investors wait CAS Medical Systems Inc (NASDAQ:CASM) to report on August, 3. its quarterly earnings Wall Street analysts expect $-0.06 EPS, up $0.02 or 25.00 % from last year’s $-0.08 same quarter earnings. CAS Medical Systems Inc’s Wall Street analysts see -25.00 % EPS growth, taking into account the $-0.08 EPS reproted in the previous quarter,

Acuta Capital Partners Llc holds 2.5% of its portfolio in CAS Medical Systems Inc for 4.18 million shares. Deerfield Management Co owns 3.20 million shares or 0.21% of their US portfolio. Moreover, 1492 Capital Management Llc has 0.06% invested in the company for 48,401 shares. The Tennessee-based Td Capital Management Llc has invested 0.01% in the stock. Blackrock Fund Advisors, a California-based fund reported 99,872 shares.#img1#

Since January 1, 0001, it had 0 buys, and 2 selling transactions for $1.24 million activity.

More notable recent CAS Medical Systems Inc (NASDAQ:CASM) news were published by: Seekingalpha.com which released: “CAS Medical Systems: Double-Digit Top-line Organic Growth, Recurring Revenue …” on February 14, 2017, also Seekingalpha.com with their article: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q4 2016 Results – Earnings Call …” published on March 09, 2017, Seekingalpha.com published: “CAS Medical Systems’ (CASM) CEO Tom Patton on Q1 2017 Results – Earnings Call …” on May 03, 2017. More interesting news about CAS Medical Systems Inc (NASDAQ:CASM) were released by: Globenewswire.com and their article: “CASMED to Report Third-Quarter 2016 Financial Results and Hold Conference Call …” published on November 02, 2016 as well as Reuters.com‘s news article titled: “BRIEF-Thomas Patton reports 5.6 pct stake in CAS Medical Systems Inc” with publication date: March 10, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.